Since variations in the promoter region may alter the transcriptional activity [103] we investigated the association of a FATP5 promoter polymorphism with parameters of the fasting and postprandial lipid and glucose metabolism in a cohort study and in subjects with histologically proven NAFLD. This evidence concerns the gene SLC27A5 and metabolic dysfunction-associated steatotic liver disease.